Login / Signup

Patient-derived renal cell carcinoma organoids for personalized cancer therapy.

Zhichao LiHaibo XuLei YuJia WangQian MengHongbing MeiZhiming CaiWei ChenWeiren Huang
Published in: Clinical and translational medicine (2022)
Patient-derived RCC organoids are valuable pre-clinical models for academic research and personalized medicine.
Keyphrases
  • renal cell carcinoma
  • cancer therapy
  • drug delivery
  • induced pluripotent stem cells